Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Fingolimod in combination with bortezomib demonstrates synergistic tumor inhibition and bone anabolic effects in myeloma bone disease

Smriti Gurung, David Halladay, Colin Crean, Parvathi Sudha, Travis Johnson, Noriyoshi Kurihara, David Roodman, John Chirgwin, Attaya Suvannasankha

Blood (2025) 146 (Supplement 1): 5727.

https://doi.org/10.1182/blood-2025-5727

Published: 2025

Journal Articles

Enhancing immunotherapy efficacy in myeloma with a novel dual-action mitochondrial toxic peptide that overcomes resistance and induces immunogenic cell death.

Smriti Gurung, Colin Crean, David Halladay, judith Anderson, John Chirgwin, Holly Lee, Nizar Bahlis, Kelvin Lee, Attaya Suvannasankha

Blood (2025) 146 (Supplement 1): 3924.

https://doi.org/10.1182/blood-2025-3924

Published: 2025

Journal Articles

Fingolimod in Combination with Bortezomib Demonstrates Synergistic Tumor Inhibition and Bone Anabolic Effects in Myeloma Bone Disease

Attaya Suvannasankha, Colin D. Crean, David Halladay, David G. Roodman, John Chirgwin

Blood (2022) 140 (Supplement 1): 7104–7105.

https://doi.org/10.1182/blood-2022-171069

Published: 2022